Condensed Consolidated Statements of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Beginning balances at Jan. 31, 2012	$ (68,266)	$ 1,899	$ 8,418,685	$ (8,488,850)	$ 0
Shares, Beginning balance at Jan. 31, 2012		1,898,727
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Net loss	(70,496)			(40,157)	(30,339)
Ending balances at Oct. 31, 2012	$ (138,762)	$ 1,899	$ 8,418,685	$ (8,529,007)	$ (30,339)
Shares, Ending balance at Oct. 31, 2012		1,898,727